Aprotinin and Deep Hypothermic Cardiopulmonary Bypass With or Without Circulatory Arrest for Craniotomy
作者:
Robert Grady,
William Oliver,
Martin Abel,
Fredric Meyer,
期刊:
Journal of Neurosurgical Anesthesiology
(OVID Available online 2002)
卷期:
Volume 14,
issue 2
页码: 137-140
ISSN:0898-4921
年代: 2002
出版商: OVID
关键词: Aprotinin;Cerebral aneurysm;Craniotomy;Hemorrhage;Circulatory arrest
数据来源: OVID
摘要:
Deep hypothermic cardiopulmonary bypass with or without circulatory arrest has been used to facilitate the surgical repair of complex cerebrovascular lesions. The advantages of deep hypothermia have been tempered by the occurrence of coagulopathy that is associated with substantial morbidity and mortality. This study analyzed retrospectively the records of 13 patients who underwent cerebrovascular neurosurgery using deep hypothermic cardiopulmonary bypass with or without circulatory arrest during the period 1993 through 1999. All patients received the serine protease inhibitor aprotinin in an effort to avoid the development of a coagulopathy, defined as hemorrhage requiring reoperation. No patients developed postoperative intracranial hemorrhage. There was also no evidence of renal dysfunction, deep venous thrombosis, myocardial infarction, or pulmonary embolism. In conclusion, this study suggests that aprotinin may be beneficial to avoid the coagulopathy that is more likely to occur if deep hypothermic cardiopulmonary bypass with or without circulatory arrest is used for craniotomy without adverse effects on renal function or apparent thrombotic complications.
点击下载:
PDF
(224KB)
返 回